{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:29:16Z","timestamp":1791894556726,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1177784"],"award-info":[{"award-number":["GNT1177784"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194811"],"award-info":[{"award-number":["GNT1194811"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtha.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T01:15:11Z","timestamp":1696986911000},"page":"581-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["When to use tranexamic acid for the treatment of major bleeding?"],"prefix":"10.1016","volume":"22","author":[{"given":"Zoe K.","family":"McQuilten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.10.001_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib2","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery","volume":"386","author":"Devereaux","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2105\/AJPH.90.4.523","article-title":"The global burden of injuries","volume":"90","author":"Krug","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jtha.2023.10.001_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/TA.0000000000002833","article-title":"Bleeding to death in a big city: an analysis of all trauma deaths from hemorrhage in a metropolitan area during 1 year","volume":"89","author":"Kalkwarf","year":"2020","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2023.10.001_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13054-015-0823-y","article-title":"Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study","volume":"19","author":"Hagemo","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.10.001_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tmrv.2011.01.001","article-title":"Trauma-induced coagulopathy--a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice?","volume":"25","author":"Curry","year":"2011","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtha.2023.10.001_bib7","first-page":"1127","article-title":"Acute traumatic coagulopathy","volume":"54","author":"Brohi","year":"2003","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.jtha.2023.10.001_bib8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/jth.14690","article-title":"Defining trauma-induced coagulopathy with respect to future implications for patient management: communication from the SSC of the ISTH","volume":"18","author":"Moore","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","author":"Moore","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2023.10.001_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ALN.0000000000004036","article-title":"Temporal transitions in fibrinolysis after trauma: adverse outcome is principally related to late hypofibrinolysis","volume":"136","author":"Rossetto","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2023.10.001_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1538-7933.2004.00593.x","article-title":"Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin","volume":"2","author":"Kwaan","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib12","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/jth.14603","article-title":"Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis","volume":"17","author":"Draxler","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtha.2023.10.001_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TA.0000000000002092","article-title":"Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner","volume":"86","author":"Barrett","year":"2019","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2023.10.001_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0040-1702170","article-title":"Fibrinolysis and the immune response in trauma","volume":"46","author":"Medcalf","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12959-022-00373-3","article-title":"Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery","volume":"20","author":"Draxler","year":"2022","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2023.10.001_bib18","doi-asserted-by":"crossref","first-page":"P1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib19","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood-2015-02-629808","article-title":"The traumatic side of fibrinolysis","volume":"125","author":"Medcalf","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.10.001_bib20","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/j.1538-7836.2012.04925.x","article-title":"Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator","volume":"10","author":"Silva","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib21","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/jth.13849","article-title":"Fibrinolysis: from blood to the brain","volume":"15","author":"Medcalf","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/emermed-2019-209181","article-title":"Biological mechanisms and individual variation in fibrinolysis after major trauma","volume":"37","author":"Coats","year":"2020","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jtha.2023.10.001_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024774","article-title":"Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice","volume":"6","author":"Guo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2023.10.001_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","author":"Gruen","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib25","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1089\/neu.2020.7527","article-title":"A\u00a0manual for the Glasgow Outcome Scale-Extended interview","volume":"38","author":"Wilson","year":"2021","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.jtha.2023.10.001_bib26","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial","volume":"156","author":"Guyette","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtha.2023.10.001_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","article-title":"Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury","volume":"6","author":"Shlosberg","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jtha.2023.10.001_bib28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.10.001_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00134-020-06279-w","article-title":"Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials","volume":"47","author":"Lawati","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00134-019-05879-5","article-title":"Is tranexamic acid going to CRASH the management of traumatic brain injury?","volume":"46","author":"Taccone","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00134-020-06305-x","article-title":"Tranexamic acid in traumatic brain injury: systematic review and meta-analysis trumps a large clinical trial?","volume":"47","author":"Maas","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib33","unstructured":"National Blood Authority (NBA). Patient blood management guidelines for adults with critical bleeding; 2023. https:\/\/www.blood.gov.au\/system\/files\/documents\/Guideline%20Patient%20blood%20management%20guideline%20for%20adults%20with%20critical%20bleeding.pdf. [accessed August 14, 2023]."},{"key":"10.1016\/j.jtha.2023.10.001_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.10.001_bib35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0041-1725097","article-title":"Tranexamic acid treatment for trauma victims","volume":"47","author":"Roberts","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bja.2022.03.032","article-title":"Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data","volume":"129","author":"Nutbeam","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtha.2023.10.001_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijgo.14201","article-title":"Alternative routes to intravenous tranexamic acid for postpartum hemorrhage: a systematic search and narrative review","volume":"158","author":"Shakur-Still","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jtha.2023.10.001_bib38","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","article-title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"19","author":"Meretoja","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtha.2023.10.001_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.721125","article-title":"Early tranexamic acid in intracerebral hemorrhage: a meta-analysis of randomized controlled trials","volume":"12","author":"Jiao","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtha.2023.10.001_bib41","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib42","first-page":"CD012964","article-title":"Antifibrinolytic drugs for treating primary postpartum haemorrhage","volume":"2","author":"Shakur","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2023.10.001_bib43","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(17)31947-5","article-title":"Tranexamic acid for post-partum haemorrhage in the WOMAN trial","volume":"390","author":"Letson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(17)31946-3","article-title":"Tranexamic acid for post-partum haemorrhage in the WOMAN trial","volume":"390","author":"Dennis","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib45","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1213\/ANE.0000000000004881","article-title":"Postpartum hemorrhage: wherefore art thou, hyperfibrinolysis?","volume":"131","author":"Butwick","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2023.10.001_bib46","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1213\/ANE.0000000000004796","article-title":"Thromboelastographic assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective single-center observational study","volume":"131","author":"Arnolds","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2023.10.001_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/aogs.14279","article-title":"Clinical value of early assessment of hyperfibrinolysis by rotational thromboelastometry during postpartum hemorrhage for the prediction of severity of bleeding: a multicenter prospective cohort study in the Netherlands","volume":"101","author":"Tahitu","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jtha.2023.10.001_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12884-018-1794-1","article-title":"Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage","volume":"18","author":"Roberts","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jtha.2023.10.001_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ALN.0000000000004020","article-title":"Fibrinolysis and trauma outcomes","volume":"136","author":"Myles","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2023.10.001_bib50","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jtha.2022.11.036","article-title":"Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study","volume":"21","author":"de Lloyd","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib51","first-page":"112","article-title":"Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. a NATA consensus statement","volume":"17","author":"Mu\u00f1oz","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtha.2023.10.001_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.14116","article-title":"FIGO recommendations on the management of postpartum hemorrhage 2022","volume":"157","author":"Escobar","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jtha.2023.10.001_bib53","series-title":"Organization recommendation on tranexamic acid for the treatment of postpartum haemorrhage","year":"2017"},{"key":"10.1016\/j.jtha.2023.10.001_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tmrv.2021.08.006","article-title":"Epidemiology of massive transfusion - a common intervention in need of a definition","volume":"35","author":"McQuilten","year":"2021","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtha.2023.10.001_bib55","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.10.001_bib56","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/CCM.0000000000005362","article-title":"Tranexamic acid in gastrointestinal bleeding: a systematic review and meta-analysis","volume":"50","author":"Dionne","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1055\/s-0035-1550437","article-title":"The fibrinolytic status in liver diseases","volume":"41","author":"Leebeek","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.10.001_bib58","first-page":"CD004328","article-title":"Tranexamic acid for patients with nasal haemorrhage (epistaxis)","volume":"12","author":"Joseph","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2023.10.001_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajem.2021.10.043","article-title":"Efficacy of topical tranexamic acid in epistaxis: a systematic review and meta-analysis","volume":"51","author":"Janapala","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.annemergmed.2020.12.013","article-title":"The use of tranexamic acid to reduce the need for nasal packing in epistaxis (NoPAC): randomized controlled trial","volume":"77","author":"Reuben","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bja.2020.07.058","article-title":"Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial","volume":"126","author":"Grassin-Delyle","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtha.2023.10.001_bib62","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/1471-0528.17455","article-title":"Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births","volume":"130","author":"Shakur-Still","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2023.10.001_bib63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bja.2021.10.054","article-title":"Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers","volume":"128","author":"Grassin-Delyle","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtha.2023.10.001_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MBC.0000000000001008","article-title":"Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in\u00a0vivo","volume":"32","author":"Draxler","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2023.10.001_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajem.2016.10.054","article-title":"Comparison of tranexamic acid plasma concentrations when administered via intraosseous and intravenous routes","volume":"35","author":"Boysen","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jtha.2023.10.001_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtha.2023.10.001_bib67","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-021-03799-9","article-title":"Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis","volume":"25","author":"Murao","year":"2021","journal-title":"Crit Care"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:41:27Z","timestamp":1761536487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623007353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1538783623007353"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.001","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When to use tranexamic acid for the treatment of major bleeding?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}